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Background: Recently, different genetic variants located within the IL2/IL21 genetic region as well as within both
IL2RA and IL2RB loci have been associated to multiple autoimmune disorders. We aimed to investigate for the first
time the potential influence of the IL2/IL21, IL2RA and IL2RB most associated polymorphisms with autoimmunity on
the endogenous non-anterior uveitis genetic predisposition.
Methods: A total of 196 patients with endogenous non-anterior uveitis and 760 healthy controls, all of them from
Caucasian population, were included in the current study. The IL2/IL21 (rs2069762, rs6822844 and rs907715), IL2RA
(2104286, rs11594656 and rs12722495) and IL2RB (rs743777) genetic variants were genotyped using TaqMan® allelic
discrimination assays.
Results: A statistically significant difference was found for the rs6822844 (IL2/IL21 region) minor allele frequency in
the group of uveitis patients compared with controls (P-value=0.02, OR=0.64 CI 95%=0.43-0.94) although the
significance was lost after multiple testing correction. Furthermore, no evidence of association with uveitis was
detected for the analyzed genetic variants of the IL2RA or IL2RB loci.
Conclusion: Our results indicate that analyzed IL2/IL21, IL2RA and IL2RB polymorphisms do not seem to play a
significant role on the non-anterior uveitis genetic predisposition although further studies are needed in order to
clear up the influence of these loci on the non-anterior uveitis susceptibility.
Keywords: Uveitis, IL2, IL21, IL2RA, IL2RB, Polymorphisms, Association study, Genetic susceptibilityBackground
Uveitis is an intraocular inflammatory disorder mediated
by a wide range of causes, including exogenous and en-
dogenous agents. This condition is considered a major
source of visual impairment being the fourth cause of
blindness worldwide [1,2]. Endogenous uveitis is an in-
flammatory response mediated by immune system
driven for a loss of tolerance against ocular antigens [3].* Correspondence: mccenit@ipb.csic.es
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reproduction in any medium, provided the orA shared genetic component among different auto-
immune diseases is well established. This fact has sug-
gested that these disorders may be influenced by both
disease-specific and common molecular mechanisms [4].
Indeed, the autoimmune uveitis also seems to share
common genetic factors with other autoimmune disor-
ders [5]. To date, different studies have been conducted
in order to identify the uveitis genetic component [6-9],
although results have been inconclusive. It is important
to note that the majority of studies on uveitis suscepti-
bility have been focused on anterior uveitis and few
studies have been carried out to determine the non-
anterior uveitis genetic background.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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crine product from activated T cells, although later was
found that IL-2 plays a crucial role in the maintenance of
immune system homeostasis and self-tolerance [10]. The
main non-redundant function of this cytokine seems to be
the regulation of peripheral tolerance by supporting the
survival and function of regulatory T cells. In fact, mice
deficient in IL-2, IL-2Rα, and IL-2Rβ exhibit autoimmun-
ity [11,12]. In uveitis condition, IL-2 induces the expan-
sion of Th17 cells, which were found to be elevated in
uveitis patients [13]. Moreover, Daclizumab therapy, a
monoclonal antibody against alpha subunit of the IL-2 re-
ceptor, reduces the active uveitis inflammation [14].
On the other hand, interleukin 21 (IL-21) is a potent im-
munomodulatory cytokine with pleiotropic effects on both
innate and adaptive immune responses. IL-21 is produced
mainly by CD4+ T cells and promotes the effector CD8+
T cells and NK cells function and expansion. In addition,
it is also critical for B-cell differentiation into plasma cells
and negatively regulates the function of dendritic cells
[15]. Recently, it has been suggested that the dendritic
cells maduration seems play a role in the pathogenesis of
endogenous uveitis [16]. Furthermore, IL-21 seems to be
involved in the Behçet’s disease (BD) [17] as well as in the
Vogt-Koyanagi-Harada (VKH) syndrome pathogenesis
[18], both disorders strongly characterized by the pre-
sence of uveitis condition, probably by promoting IL-17
secretion.
Different studies with animal models have clearly sup-
ported the involvement of IL-21 as well as IL2/IL2R
pathway as potential drivers of autoimmunity [19-24].
Additionally, genetic associations between different poly-
morphisms located within the IL2/IL21 region as well as
within both IL2RA and IL2RB loci and several auto-
immune diseases have also been reported [25-34].
Regarding the IL2RA gene, different independent signals
on this gene were identified by fine mapping of the region,
and their minor alleles were related to inherited lower cir-
culating levels of the soluble IL-2RA protein, [25-27,29].
IL-2RA is expressed constitutively on regulatory T cells, a
population of T cells that has been shown to have a potent
ability to suppress autoreactive T cells [35].
Taking into account all of the above, we herein aimed
to investigate whether the previously most associated
polymorphisms with different autoimmune disorders lo-
cated in the IL2/IL21, IL2RA and IL2RB loci are involved
in the genetic predisposition to autoimmune uveitis. For
this purpose, we studied three SNPs located within the
IL2/IL21 region (rs907715, located within the IL21 gene
and most associated SNP with SLE in a recent fine map-
ping, rs2069762 situated within the IL2 gene and
rs6822844 positioned in the IL2/IL21 inter-genic region),
three functional independent Single Nucleotide Poly-
morphisms (SNPs) related with lower circulating levelsof the soluble IL-2RA (rs11594656, rs2104286 and
rs12722495) and one SNP in the IL2RB locus
(rs743777), all of them previously associated to multiple




We included a total of 196 patients with endogenous
uveitis, excluding the anterior uveitis forms as well as
uveitis associated with systemic immune-mediated dis-
eases except Vogt-Koyanagi-Harada syndrome, and 760
ethnically matched healthy controls, all of them from
Caucasian population. Furthermore, uveitis patients
were classified depending on the part of eye affected by
the inflammatory process in intermediate uveitis (IU),
posterior uveitis (PU) or panuveitis (PAN) [36]. Written
informed consent and approval of the local ethical com-
mittees were obtained and the research followed the te-
nets of the Declaration of Helsinki. The design of the
work was approved by the Ethics Committee of Granada
(Spain). The Ethics Committees of the Hospital de León
(León), Hospital Universitario Príncipe de Asturias
(Alcalá de Henares), Hospital de Cruces (Bilbao),
Hospital Clinic (Barcelona), Hospital Clínico San Carlos
(Madrid), Hospital Marqués de Valdecilla (Santander),
Hospital Universitario La Fe (Valencia), Hospital Clínico
San Cecilio (Granada) and Hospital Carlos Haya
(Málaga) also approved the study.
Genotyping and SNP selection
Genomic DNA was extracted from peripheral white blood
cells following standard procedures. The single-nucleotide
polymorphisms (SNPs) were genotyped using pre-
designed TaqMan® allelic discrimination assays in a
7900HT Real-Time polymerase chain reaction (PCR)
System from Applied Biosystems (Foster City, CA, USA).
We carried out the genotyping of the rs2069762,
rs6822844 and rs907715 genetic variants, located within
the 4q27 (IL2/IL21) region, rs11594656, rs2104286 and
rs12722495 in the IL2RA gene and rs743777 located
within the IL2RB locus.
Statistical analysis
The Linux software Plink v1.7 (http://pngu.mgh.harvard.
edu/purcell/plink/) was used to perform 2x2 contingency
tables, χ2 and/or Fisher’s exact tests, when appropriate.
The genotype, allele and carrier frequencies were com-
pared between patients, subgroup of patients and controls.
Odds ratios (OR) and 95% confidence intervals (CI) were
obtained according to Woolf ’s method. Hardy–Weinberg
equilibrium (HWE) was tested for all SNPs at significance
level=0.01. Since different polymorphisms were analyzed
in the current study, the Benjamini & Hochberg (1995)
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multiple testing was applied to the P-values. P-values after
FDR correction lower than 0.05 were considered as statis-
tically significant.
Furthermore, the effect of the analyzed genetic vari-
ants located within the 4q27 as well as within the IL2RA
gene was analyzed either in isolation or by allelic com-
bination analysis in order to cover a higher variability of
these chromosome regions.
The overall statistical power of our study according to
Power Calculator for Genetic Studies 2006 software
(http://www.sph.umich.edu/csg/abecasis/CaTS/), is shown
in online Additional file 1: Table S1.
Results
Table 1 describes the main clinical and demographic
characteristic of uveitis patients included in the current
study and Table 2 shows the genotypic and allelic fre-
quencies in cases and controls. The intraocular inflam-
mation seen in patients included intermediate uveitis
(18.4%), posterior uveitis (55.1%), and panuveitis (23.5%).
No statistically significant deviation from Hardy-
Weinberg equilibrium (P≤0.01) was observed for all the
studied SNPs in the control set and the frequencies of the
analyzed SNPs were in agreement with the data of the
HapMap project. Genotyping success rate was higher than
95% for all analyzed SNPs. In addition, randomly selected
samples were genotyped twice to verify the genotyping ac-
curacy and 99% of the genotypes were identical.
In the case/control analysis, we detected a decrease of
the minor allele frequency of the rs6822844 (IL2/IL21
region) in the group of uveitis patients (P-value=0.02,
OR=0.64 CI 95%=0.43-0.94). Nevertheless, when we ap-
plied the FDR correction the significance was lost
(PFDR=0.17) (Table 2). Additionally, no statistical signifi-
cant differences were observed in the genotype, allele
and carriers frequencies for the analyzed IIL2RA and
IL2RB SNPs between uveitis patients and controls.Table 1 Clinical and demographic features of uveitis
patients and controls
General characteristics Uveitis patients (n=196) Controls (n=760)
Male(%)/Female (%) 83 (42.3)/113 (52.1) 254 (33.4)/506 (66.6)
Age (mean ± SD) 46.3 ±15.48 45.12 ± 12.21
Intermediate Uveitis (%) 36 (18.4) -
Posterior Uveitis (%) 108 (55.1) -
Panuveitis (%) 46 (23.5) -
Bilateral affection (%) 149 (68.7) -
Vitritis (%) 135 (62.2) -
Macular edema (%) 89 (41.0) -
Retinal vasculitis (%) 83 (38.2) -
Choroidal
neovascularization (%)
20 (9.2) -When we compared the different subgroups of uveitis
patients stratified according to the different main features
showed in Table 1 no statistically significant differences
were detected for none of the analyzed polymorphisms
(data not shown).
On the other hand, the allelic combination analysis of
the studied polymorphisms located within the IL2/IL21
chromosome region as well as within the IL2RA gene
did not provide additional information (Tables 3 and 4,
respectively).
Discussion
Although the etiology of uveitis is not fully understood
yet, multiple evidences have strongly suggested that al-
terations in the immune system may underlie the dys-
function observed in endogenous uveitis [37]. To date,
different functional studies have supported that the
T-regulatory cells as well as Th17 cells seem to confer
protection from and risk to intraocular inflammation, re-
spectively [38]. IL-2 promotes development of regulatory
T cells and confers protection from autoimmune disease
[10] whereas IL-21 promotes differentiation of Th17
cells and is implicated in the development of several
autoimmune diseases [15]. Interestingly, on the one
hand IL-2 inhibits the differentiation of Th17 cells, al-
though on the other hand it induces the expansion of
Th17 cells once developed that mediate uveitis [13].
Therefore, taking into account all these evidences and
the shared genetic component among the different auto-
immune diseases, in the present study we aimed to
analyze the influence of different polymorphisms located
within the IL2/IL21, IL2RA and IL2RB loci, previously
associated to multiple autoimmune disorders, on the
non-anterior autoimmune uveitis susceptibility.
It is important to note that although we observed a
weak association of the rs6822844 IL2/IL21 polymorph-
ism with uveitis, it did not reach statistical significance
after multiple testing correction, probably due to the
large number of tests performed and the limited statis-
tical power to detect moderate effects (Additional file 1:
Table S1). For this reason, further studies are needed in
order to confirm the possible IL2/IL21 genetic region in-
fluence on the non-anterior uveitis genetic background.
This polymorphism has been studied in several auto-
immune diseases such as celiac disease, type 1 diabetes
and rheumatoid arthritis and showed a protective effect
in all of them. In this way, our results for the rs6822844
are in agreement with the effect formerly observed for
other conditions suggesting a common underlying
mechanism [31,32,34]. The rs6822844 polymorphism
probably may be acting as genetic marker of another
nearby causal polymorphism in tight linkage disequilib-
rium with it. In addition, after confirmation of the
IL2/IL21 genetic region influence on uveitis genetic
Table 2 Allelic and genotype frequencies of IL2/IL21, IL2RA and IL2RB genetic variants in uveitis patients and healthy
controls from Spanish population
SNP 1/2 Subgroup (n) 11 12 22 MAF (%) Allelic P -value OR (95% CI)
IL2/IL21
rs2069762 C/A Controls (n=760) 61 (8.03) 315 (41.45) 384 (50.53) 437 (28.75)
Uveitis (n=195) 17 (8.71) 85 (43.60) 93 (47.69) 119 (30.51) 0.49 1.09 (0.85-1.40)
rs6822844 T/G Controls (n=760) 15 (1.97) 156 (20.53) 589 (77.50) 186 (12.24)
Uveitis (n=196) 2 (1.02) 28 (14.29) 166 (84.69) 32 (8.16) 0.02* 0.64 (0.43-0.94)
rs907715 T/C Controls (n=760) 81 (10.66) 330(43.42) 349(46.92) 492 (32.37)
Uveitis (n=196) 26 (13.27) 70 (35.71) 100 (51.02) 122 (31.12) 0.64 0.94 (0.74-1.20)
IL2RA
rs12722495 G/A Controls (n=760) 3 (0.39) 114 (15.00) 643 (84.61) 120 (7.90)
Uveitis (n=196) 2 (1.02) 29 (14.80) 165 (84.18) 33 (8.42) 0.73 1.07 (0.72-1.60)
rs2104286 C/T Controls (n=760) 19 (2.50) 270 (35.53) 471 (61.97) 308 (20.26)
Uveitis (n=196) 10 (5.10) 60(30.61) 126 (64.29) 80 (20.41) 0.95 1.01 (0.77-1.33)
rs11594656 T/A Controls (n=760) 84 (11.05) 346(45.53) 330(43.42) 514 (33.82)
Uveitis (n=196) 23 (11.79) 69 (35.38) 103 (52.82) 115 (29.49) 0.10 0.82 (0.64-1.04)
IL2RB
rs743777 G/A Controls (n=760) 86(11.32) 349(45.92) 325(42.76) 521 (34.28)
Uveitis (n=195) 26 (13.40) 72 (37.11) 96 (49.48) 124 (31.96) 0.39 0.90 (0.71-1.14)
*PFDR-corrected=0.17.
SNP; Single Nucleotide Polymorphism.
MAF; Minor Allele Frequency.
OR; Odds Ratio.
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order to reveal the causal variant/s responsible and to
clear up the influence of this region on the uveitis
etiology. Importantly, a better knowledge of the uve-
itis etiology could allow a successful and more per-
sonalized treatment of the disease.
The association of IL2RA polymorphisms with auto-
immunity is more complex and a given polymorphism
may show the opposite effect in different autoimmune dis-
orders [27]. Our results indicate that the analyzed IL2RA
and IL2RB polymorphisms do not seem to play a signifi-
cant role on the non-anterior uveitis genetic predisposition,
similar to what has been reported in other autoimmune
diseases such as inflammatory bowel disease and celiac dis-
ease. In these diseases underlying mechanisms different to
the IL2-dependent pathway would probably be involved in
the perturbed development of regulatory T cells. Recently,Table 3 IL2/IL21 allelic combinations (rs2069762,
rs6822844 and rs907715) in uveitis patients and healthy
controls from Spanish population
Allelic combination Uveitis, n (%) Controls, n (%) P-value OR [95% CI]
AGC 142 (39.3) 596 (39.2) 0.95 1.01 (0.79-1.28)
CGC 106 (29.3) 432 (28.4) 0.71 1.05 (0.81-1.36)
AGT 83 (22.9) 301 (19.8) 0.17 1.21 (0.91-1.61)
ATT 28 (7.8) 185 (12.2) 0.02 0.61 (0.39-0.94)the IL2RA rs2104286 polymorphism has been associated
with intermediate uveitis [39]. When we evaluated whether
the studied genetic variants were involved in the different
uveitis forms we did not observe the any association with
the different uveitis subphenotypes. Nevertheless, this no
evidence of association between the Il2RA locus and inter-
mediate uveitis must be taken with caution because, al-
though the statistical power of the overall analysis in the
present study is high (Additional file 1: Table S1; 99% at
the 5% significant level to identify the previously detected
OR equal to 0.52), the statistical power of the stratified
analysis for different uveitis forms is limited and, probably,
moderate effects are hardly detected.
Conclusions
Therefore, our results suggest that analyzed IL2/IL21,
IL2RA and IL2RB polymorphisms do not seem to play aTable 4 IL2RA allelic combinations (rs12722495, 2104286
and rs11594656) in uveitis patients and healthy controls
from Spanish population
Allelic combination Uveitis, n (%) Controls, n (%) P-value OR [95% CI]
ATA 195 (50.8) 714 (47.0) 0.21 1.15 (0.92-1.45)
ATT 112 (29.1) 498 (32.6) 0.16 0.84 (0.65-1.08)
ACA 46 (12.0) 186 (12.4) 0.86 0.97 (0.68-1.39)
GCA 29 (7.5) 106 (7.0) 0.71 1.08 (0.69-1.69)
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disposition although additional studies are needed to
draw firm conclusions about the exact role of the ana-
lyzed genes in the susceptibility and clinical spectrum of
uveitis.Additional file
Additional file 1: Table S1. Overall statistical power for each analyzed
genetic variant at the 5% significance level.
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